Cargando…
Usefulness of KL-6 for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients
Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial lung disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict clinical outcomes in hospitalized coronavirus disease 2019 (COVID-19) patients. Methods: In a total of 48 hospitalized COVID-...
Autores principales: | Park, Mikyoung, Hur, Mina, Kim, Hanah, Lee, Chae Hoon, Lee, Jong Ho, Nam, Minjeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608840/ https://www.ncbi.nlm.nih.gov/pubmed/36295478 http://dx.doi.org/10.3390/medicina58101317 |
Ejemplares similares
-
Novel Usefulness of Krebs von den Lungen 6 (KL-6) with Hemoglobin and Lactate Dehydrogenase for Assessing Bone Marrow Fibrosis
por: Nam, Minjeong, et al.
Publicado: (2022) -
Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients
por: Park, Mikyoung, et al.
Publicado: (2023) -
Prognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients
por: Park, Mikyoung, et al.
Publicado: (2022) -
Distribution of Presepsin, Krebs von den Lungen 6, and Surfactant Protein A in Umbilical Cord Blood
por: Nam, Minjeong, et al.
Publicado: (2022) -
Digital Morphology Analyzer Sysmex DI-60 vs. Manual Counting for White Blood Cell Differentials in Leukopenic Samples: A Comparative Assessment of Risk and Turnaround Time
por: Nam, Minjeong, et al.
Publicado: (2022)